Q66F89 AF NFT

Peptide methionine sulfoxide reductase MsrA

MOLNFT AF v1 smart contract in GenesisL1 blockchain:
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata:
bafybeih3byztvgzykarsobjckd2dtvz2rymiavswdjpk72bwykmxmualja/metadata.json
IPFS of structure file:
bafybeia7gjqz2cl4upcxzffeo63hs367blw5vxjym5fykwwbxw4q3lmcwm/AF-Q66F89-F1-model_v2.pdb
First NFT owner address (eip-55):
0x1ED4a68B4011314730adE976b56Ad4cA21b54dcD
First NFT owner address (bech32):
genesis1rm22dz6qzyc5wv9da9mt26k5egsm2nwdw6hzk8
Current NFT ID #245916 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT Q66F89 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q66F89|MSRA_YERPS Peptide methionine sulfoxide reductase MsrA OS=Yersinia pseudotuberculosis serotype I (strain IP32953) OX=273123 GN=msrA PE=3 SV=1 MQNVDNTAVIDAANALPGRLTSIPVSPLHAVHGHSMTYIPEGMDLAFFAMGCFWGAERLFWQQPGVYSTAAGYSGGHTPNPTYHEVCSGRTGHAEVVRVVFDPAVISYQQLLQIFWENHDPAQGMRQGGDVGTQYRSAIYVLTPEQEEQAHKSRERFQQAMEKAGDQRVITSEITVALPFYYAEDDHQQYLHKNPHGYCGLGGIGVCLPPNV